Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Levamlodipine vs Amlodipine and Food Effect
NCT03657550Phase 1Completed
- Sponsor
- Conjupro Biotherapeutics, Inc.
- Start
- May 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Levamlodipine in hypertension (HTN) (2 arms), sponsored by Conjupro Biotherapeutics, Inc. Primary endpoint: Plasma concentration of study drugs at 6 weeks. Started May 2018; status: completed.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03657550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03657550.